The urokinase receptor (uPAR, CD87) as a target for tumor therapy: uPA-silica particles (SP-uPA) as a new tool for assessing synthetic peptides to interfere with uPA/uPA-receptor interaction.

Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer

Volumn 162, Issue , 2003, Pages 3-14

  Guthaus, Elke ^a   Schmiedeberg, Niko ^a   Bürgle, Markus ^a   Magdolen, Viktor ^a   Kessler, Horst ^a   Schmitt, Manfred ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; LIGAND; PEPTIDE; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS;

ANIMAL; BIOLOGICAL MODEL; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CHEMISTRY; FLOW CYTOMETRY; HUMAN; METABOLISM; NEOPLASM; PROTEIN BINDING; REVIEW;

ANIMALS; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; FLOW CYTOMETRY; HUMANS; LIGANDS; MODELS, BIOLOGICAL; NEOPLASMS; PEPTIDES; PROTEIN BINDING; RECEPTORS, CELL SURFACE;

MLCS; MLOWN;

EID: 0041781040     PISSN: 00800015     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-59349-9_1     Document Type: Review

References (50)